Natural Products of Pharmacology and Mechanisms in Nucleus Pulposus Cells and Intervertebral Disc Degeneration
Open Access
- 3 August 2021
- journal article
- review article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-22
Abstract
Intervertebral disc degeneration (IDD) is one of the main causes of low back pain (LBP), which severely reduces the quality of life and imposes a heavy financial burden on the families of affected individuals. Current research suggests that IDD is a complex cell-mediated process. Inflammation, oxidative stress, mitochondrial dysfunction, abnormal mechanical load, telomere shortening, DNA damage, and nutrient deprivation contribute to intervertebral disc cell senescence and changes in matrix metabolism, ultimately causing IDD. Natural products are widespread, structurally diverse, afford unique advantages, and exhibit great potential in terms of IDD treatment. In recent years, increasing numbers of natural ingredients have been shown to inhibit the degeneration of nucleus pulposus cells through various modes of action. Here, we review the pharmacological effects of natural products on nucleus pulposus cells and the mechanisms involved. An improved understanding of how natural products target signalling pathways will aid the development of anti-IDD drugs. This review focuses on potential IDD drugs.Keywords
Funding Information
- Lanzhou University (20JR10RA735, YJSBD-09, cxcy201906, GZK-2019-46, CY2019-MS10)
- Special Fund Project for Doctoral Training Programme of Lanzhou University Second Hospital (20JR10RA735, YJSBD-09, cxcy201906, GZK-2019-46, CY2019-MS10)
- Lanzhou University Innovation and Entrepreneurship Cultivation Project (20JR10RA735, YJSBD-09, cxcy201906, GZK-2019-46, CY2019-MS10)
- Chinese Medicine Administration Research Project of Gansu Province (20JR10RA735, YJSBD-09, cxcy201906, GZK-2019-46, CY2019-MS10)
- Cuiying Technology Innovation Project of Lanzhou University Second Hospital (20JR10RA735, YJSBD-09, cxcy201906, GZK-2019-46, CY2019-MS10)
This publication has 159 references indexed in Scilit:
- Biosynthesis and biotechnological production of ginsenosidesBiotechnology Advances, 2015
- MMPs and ADAMTSs in intervertebral disc degenerationClinica Chimica Acta, 2015
- Mechanics and biology in intervertebral disc degeneration: a vicious circleOsteoarthritis and Cartilage, 2015
- The re-emergence of natural products for drug discovery in the genomics eraNature Reviews Drug Discovery, 2015
- Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc DegenerationPLOS ONE, 2014
- Effect of Citrus Flavonoids, Naringin and Naringenin, on Metabolic Syndrome and Their Mechanisms of ActionAdvances in Nutrition, 2014
- Mitochondrial‐derived reactive oxygen species (ROS) play a causal role in aging‐related intervertebral disc degenerationJournal of Orthopaedic Research, 2013
- Targeting ASIC3 for pain, anxiety, and insulin resistancePharmacology & Therapeutics, 2012
- Osthole, a herbal compound, alleviates nucleus pulposus-evoked nociceptive responses through the suppression of overexpression of acid-sensing ion channel 3 (ASIC3) in rat dorsal root ganglionMedical Science Monitor, 2012
- Growth Factors and Anticatabolic Substances for Prevention and Management of Intervertebral Disc DegenerationStem Cells International, 2011